Horizon Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$106K Buy
420
+271
+182% +$58.3K 0.04% 101
2026
Q1
$32.3K Buy
149
+64
+75% +$14.2K 0.01% 130
2025
Q4
$19.3K Buy
85
+29
+52% +$6.61K 0.01% 142
2025
Q3
$12.9K Buy
56
+26
+87% +$5.29K 0.01% 163
2025
Q2
$5.65K Hold
30
﹤0.01% 158
2025
Q1
$6.32K Sell
30
-5
-14% -$972 ﹤0.01% 135
2024
Q4
$6.23K Hold
35
﹤0.01% 137
2024
Q3
$6.86K Sell
35
-34
-49% -$6.35K ﹤0.01% 140
2024
Q2
$11.9K Buy
69
+29
+73% +$4.8K 0.01% 124
2024
Q1
$7.29K Buy
+40
New +$6.89K ﹤0.01% 144
2022
Q1
Sell
-40
Closed -$5.42K 57
2021
Q4
$5.42K Buy
40
+10
+33% +$1.18K ﹤0.01% 103
2021
Q3
$3K Hold
30
﹤0.01% 123
2021
Q2
$3K Hold
30
﹤0.01% 111
2021
Q1
$3K Buy
+30
New +$3.21K ﹤0.01% 88

Other funds holding ABBV

Horizon Financial Services's ABBV Position: Q2 2026 in Review

Horizon Financial Services increased its AbbVie (ABBV) stake by 182% in Q2 2026, buying an estimated $58.3K and bringing the position to 420 shares worth $106K. The position accounts for 0.04% of the portfolio, ranked #101.

Horizon Financial Services first reported a position in ABBV in Q1 2021 and has held it in 14 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Horizon Financial Services held 420 shares of AbbVie worth $106K as of Q2 2026.
  • Horizon Financial Services bought 271 AbbVie shares in Q2 2026, an estimated $58.3K.
  • AbbVie made up 0.04% of Horizon Financial Services's portfolio in Q2 2026, its #101 holding.
  • Horizon Financial Services first reported a position in AbbVie in Q1 2021 and has held it in 14 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Horizon Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.